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Abstract  
In biosensor experiments, ligand molecules need to be immobilized tightly on sensor surfaces 
for sensitive and robust detection of the analyte of interest. Stretches of histidines (His-tags) are 
typically inserted into recombinant proteins for affinity purification purposes, but can also be 
used in the immobilization of biosensors functionalized with Ni-NTA (nitrilotriacetic acid). The 
His-tag - Ni-NTA bond is, however, easily disrupted by factors including low pH, reducing agents, 
or chelating agents such as EDTA. In biosensing applications, a stable ligand immobilization that 
tolerates harsh conditions is preferable, because the sample matrix can vary from bodily fluids 
to waste waters. We describe here Co(III)-NTA bonding for tight immobilization of His-tagged 
proteins on Octet BLI-biosensors. The performance of the Ni(II)-NTA was compared to that of 
Co(III)-NTA using His-tagged avidins and norovirus proteins. Comparative studies were 
performed using biotin-iminodiacetic acid (IDA) for streptavidin sensor functionalization instead 
of the NTA surfaces provided by the manufacturer. It was noted that Co(III)-NTA offers highly 
stable immobilization of His-tagged protein, tolerating factors such as 0.7 M imidazole, that is 
typically used for detaching proteins from Ni(II)-NTA -agarose used in protein purification 
columns. The good performance of Co(III)-NTA functionalized BLI sensor was demonstrated by 
detecting norovirus antibodies from human serum samples with sensors functionalized with His-
tagged virus-like particles. The use of Co-NTA sensors for attachment of His-tagged proteins is 
ideal in conditions, where the immobilized ligands need to be firmly attached and tolerate harsh 
chemical conditions. 
This is the accepted manuscript of the article, which has been published in Sensors and Actuators B: 
Chemical. 2017, 243, 104-113. https://doi.org/10.1016/j.snb.2016.11.090
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1. Introduction 
Histidine tags, e.g. insertion of a stretch of 5-10 histidine amino acids in either the N- or C-
terminus of a recombinant protein, are typically used as affinity tags for purification purposes [1-
3]. Proteins with a histidine tag bind specifically to metal-functionalized affinity columns, from 
which they can be detached (for example by mild acid or imidazole treatment) and subsequently 
collected and separated from the source material. When the column is reloaded with metal 
(nickel, cobalt, zinc), it is readily available for reuse. Iminodiacetic acid (IDA) and nitrilotriacetic 
acid (NTA) are typically used as chelating agents for the immobilization of the metal. 
But there are occasions when it would be ideal to use His-tags for more stable immobilization, 
such as the permanent functionalization of biosensors. In these applications, the reasonably easy 
detachment of His-tagged proteins from the metal-functionalized materials poses a problem. For 
example, the low concentrations of EDTA typically used as preservative in many commercial 
solutions are sufficient to detach the His-tagged protein from Ni-NTA. Originally, the idea of tight 
immobilization of His-tagged protein binding to agarose-NTA columns via cobalt(III) instead of 
nickel, was studied by Hale [4], where antibody affinity columns were constructed. Recently 
Wegner et al. [5-6] have continued the development of cobalt-based immobilization with NTA-
agarose and quartz crystal microbalance (QCM) sensors and proposed much more stable bonding 
of His-tagged proteins via Co(III)-NTA. Here the oxidation state of the cobalt is changed from state 
(II) to (III), which turns the complex into a slowly exchanging state, thus slowing down both the 
association and dissociation processes. In practice, this approach requires the formation of the 
complex in with cobalt in a reduced state (Co(II)), which is then converted to an oxidized state 
(Co(III)), using an oxidizer such as hydrogen peroxide.  
Biolayer interferometry (BLI) is a label- and fluidics-free detection method that is also suitable for 
use with difficult sample matrices, such as serum. BLI is based on light intensity interference and 
enables real-time monitoring of ligand association or dissociation within the samples [7-10]. 
Interference changes between the intensities of the reflected light beams are used to measure 
changes in the molecular layer immobilised on the sensor surface. In the BLI measurement set-up 
the sensor tip is dipped into the sample matrix, even making difficult-to-process bodily fluids (such 
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as saliva, urine, whole blood and stool) suitable sample materials. This approach makes it possible 
to operate with small sample volumes. 
Avidins are tetrameric molecules capable of binding very tightly (with fM affinity) to four 
molecules of biotin (vitamin H) [11]. Originally avidins were extracted from chicken egg yolk and 
since, have been studied thoroughly and applied in several biotechnological applications [12-14]. 
One example of engineered avidin is so called chimeric avidin (ChiAvd) [15], which is stable at very 
high temperatures, as well as within high concentrations of organic solvents [16]. In addition to 
these superior stability characteristics, the surface properties of the molecule were also changed 
in order to make the pI of the molecule more neutral, which resulted in lower non-specific 
protein-protein interactions in neutral conditions [17], thus making it a very suitable molecule for 
biosensing applications. In the current study, this neutralized chimeric avidin (nChiAvd) was also N-
terminally His-tagged. A schematic figure of the tetrameric avidin molecule used in this study 
exhibiting all characteristic mutations as well as the locations of the biotin binding sites is shown in 
the supplementary material, Fig. S1. 
Noroviruses (NoV) infect people of all ages and are a major cause of acute epidemic gastroenteritis 
worldwide. It has been estimated that annually, there are over 20 million infections in the United 
States alone [18]. Symptoms of infection appear within 12 – 48 hours and are characterised by 
acute onset of nausea, vomiting, abdominal cramps and diarrhoea. Small children, elderly people 
and immunocompromised persons can be severely infected by the virus and may require 
hospitalisation to prevent severe dehydration. Noroviruses are spread by contaminated food and 
water and from person to person via the faecal-oral pathway. They can be further transmitted to 
food and food contact surfaces by hands that are contaminated with the virus [19-20]. Virus-like 
particles (VLPs) have been used extensively to study NoV structure and stability, host-cell 
interactions, and as a tool in diagnostic serological assays [20-23]. Structural studies have shown 
that NoV capsid is composed almost entirely of the 58 kDa VP1 capsid protein [21], which self-
assembles into empty capsids called virus-like particles (VLPs) when expressed recombinantly in 
insect cells [24], in yeast [25] or in plant cells [26]. There are 180 copies of VP1 in one NoV particle, 
and the diameter of the capsid is approximately 40 nm [27]. VP1 consists of two domains, the shell 
(S) domain and the protruding (P) domain, which are linked by a short hinge. 12 P-domain dimers 
form the NoV P-particle, the diameter of which is approximately 10-15 nm [28]. In this study we 
utilized recombinant NoV antigens, P-particles and norovirus-like particles (nVLPs). 
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In our previous study, detection of norovirus antibodies from serum samples was conducted using 
BLI [29]. In order to increase the sensitivity of antibody detection, the BLI signal was enhanced 
through the addition of DAB (3,3´-diaminobenzidine), which precipitates on the sensor surface 
after horseradish peroxidase (HRP) oxidation [29-32]. However, the commercial DAB-reagents 
contain EDTA, which acts as a preservative stabilizing DAB. This makes the reliable use of a His-tag 
– metal immobilization strategy impossible, as the EDTA causes the dissociation of the His-tagged 
proteins from the sensor surfaces. For the above reason, alternative options for use of His-tag 
protein immobilization are needed. 
In this study, we have studied cobalt-mediated immobilization of His-tagged proteins on BLI-
biosensor surfaces. We utilized engineered avidin molecules and norovirus-like particles as ligands 
and demonstrated tight immobilization of these proteins onto sensors as well as the excellent 
detection of antibodies in human serum. NTA-Co(III) immobilization offers a stable and robust 
immobilization method and combined with BLI, it enables very fast and sensitive detection of 
analytes from both small sample volumes (40 µl) and challenging sample matrices.     
 
2. Materials and methods 
A schematic presentation of the approach utilized in this study is shown in Fig. 1A. In the initial 
phase, Co-IDA surfaces were prepared; biotin-IDA molecules were immobilized on streptavidin 
(SA) sensors that made up a basement layer. Ni-NTA sensors provided by the manufacturer (Pall 
ForteBio, Menlo Park, CA, USA) were used as such as controls, but in contrast, the Co-NTA surfaces 
were made by stripping the metal ions from Ni-NTA sensors with EDTA, and then reloading the 
sensors with cobalt. In the second phase, avidin molecules were immobilized via their histidine-
tags to either the Co-IDA, Ni-NTA or to the Co-NTA sensors. It is noteworthy, as shown in the 
schematics, that there are fewer binding sites available in the IDA-functionalized sensors when 
compared to the NTA-functionalized sensors: in theory only one available binding site in each IDA-
functionalized sensor compared to three available binding sites in each NTA-functionalized sensor. 
This is because tris-NTA molecules [33] are used in the manufacturing of Ni-NTA sensors. The 3rd 
phase consists of oxidation of the sensors, which converts the cobalt to the oxidized state (Co(III)). 
Then follows the challenging of the sensors by imidazole or low pH flush to evaluate the stability of 
the bonds between the protein and the sensor. In the last phase, the binding of the biotinylated-
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BSA is used to confirm the functionality of the sensor. Fig. 1B shows all these phases as 
representative BLI-sensorgrams. 
 
[Figure 1 here] 
 
Fig. 1. Experimental setup. (A) Schematic presentation of the different phases of the biosensing 
experiment studied with BLI (B) Typical BLI-sensorgrams showing the different phases described in 
the schematic presentation in (A). Solid lines correspond to experiments conducted under ideal 
conditions, while dashed lines represent experiments where the sensors were subjected to 
challenge with imidazole, which in the case of Ni-NTA, lead to an almost complete dissociation of 
the ligand from the sensor surface (phase 4). 
 
Interferometry biosensing is based on the measurement of white light interference patterns 
reflected from a reference surface and a biofunctionalised sensor surface. A Fortebio Octet 
RED384 instrument equipped with 16 parallel biosensors (Pall ForteBio, Menlo Park, USA) was 
used in this study. All reagents were of analytical grade.  
 
2.1. Protein molecules 
2.1.1. His-tagged nChiAvd  
His-tagged nChiAvd [17] was produced in BL21-AI cells using pYU25 plasmid (gift from Prof. Lloyd 
Ruddock, University of Oulu) as described by Hytönen et al. [34]. pYU25 encodes a polycistronic 
cassette containing N-terminally His-tagged nChiAvd with the components for cytoplasmic 
disulfide bond formation (ERv1p and PDI). It is similar in structure to pKEHS1160 [35] which 
encodes BMP4 plus the components required for cytoplasmic disulfide bond formation, except 
that in pYU25, the ERv1p and PDI codons are optimized for E. coli expression and the T7 promoter 
has been replaced with a Ptac promoter. Codon optimization and gene synthesis were performed 
by GenScript. 
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2.1.2. Biotinylated-BSA 
Bovine serum albumin (BSA) molecules were biotinylated with EZ-Link Sulfo-NHS-SS-Biotin 
(Thermo Scientific, Waltham, MA, USA) as previously described [15]. 
 
2.1.3. NoV P-particles and VLPs 
The production and purification of recombinant P-particles and His-tagged VLPs are described by 
Koho et al. [24] and Koho et al. [36] respectively. Briefly, a C-terminal polyhistidine tag was added 
to the GII-4 NoV capsid protein sequence by polymerase chain reaction using primers that 
contained the His-tag sequence. His-tagged NoV VLPs were expressed in insect cells and the His-
tagged norovirus P-particles in E. coli using the methodology described in [24] and both were 
purified by Ni-NTA metal ion affinity chromatography. Samples of His-tagged norovirus P-particle 
are available from BioMediTech ProtMarket 
(http://www.biomeditech.fi/Protein_Shop/products.html). 
 
2.2. Serum samples 
Serum samples from NoV-infected subjects were collected as a part of a prospective etiological 
study at Tampere University Hospital in 2006-2008 [23-24] and stored at −20°C until they were 
used. The study protocol was approved by the appropriate Ethics Committee, and informed 
patient consent was obtained. 
 
2.3. BLI-measurements 
The Ni-NTA or SA sensor surfaces (Pall ForteBio, Menlo Park, USA) were functionalized with either 
neutralized histidine-tagged chimeric avidin, NoV VLP or with P-particles at a concentration of 50 
µg/ml, 40 µg/ml or 60 µg/ml, respectively, in PBS (10 mM NaPO3, 150 mM NaCl, pH 7.4). PBS was 
used as a liquid phase in all of the BLI sensor functionalization steps. The sensors were soaked 
prior to run for 15-60 minutes in running buffer according to the manufacturer instructions. In 
these experiments only fresh, new sensors were used. The number of the sensors used was 
typically 2-6 per analyte and the data is presented as average ± standard deviation of the 
measured responses. The stirring speed was set at 500 rpm, apart from with serum samples in the 
DAB-enhancement where 100 rpm was used. The temperature was fixed at 25°C. Black, tilted-
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bottom 384-well plates (Pall ForteBio, Menlo Park, USA) were used for sample measurement to 
ensure minimal drift in the measured signal between the analysis steps. 
Typically, a BLI running set-up with Ni-NTA sensors and avidin-ligands was performed as follows: 1) 
the baseline of the sensors and device in buffer without any binding events was recorded first for 
1 minute. 2) Sensors destined for coupling with cobalt, were soaked in 50 mM EDTA (ethylene 
diamine tetra-acetic acid) pH 8 for 6 min. The Ni-sensors run in parallel were soaked in PBS. 3) 
After each step the sensors were washed in PBS for 5 minutes. 4) Sensors were soaked in CoCl2 in 
double distilled deionized water (DDIW) at a concentration of 100 mg/ml for 6 minutes (the 
control Ni-sensors were soaked in plain PBS). 5) His-tagged nChiAvd (50 µg/ml in PBS) was 
immobilised on the sensors for 6 minutes. 6) 0.3% H202 -oxidation (tested H202 concentration 
range was 0.03-0.3%) took place for 10-15 minutes (tested in a range of 5-60 min) (the non-
oxidized control Ni-sensors were soaked in plain PBS during the Co-sensor oxidation phase). 7) If 
the sensors were challenged with 0.7 M imidazole, or 1 M acetic acid pH 2 for 6 minutes, it took 
place in this phase. 8) The binding of the second layer protein (biotinylated-BSA, 50 ug/ml in PBS) 
was measured for 6 minutes. 
When running the serum samples with NoV VLP or P-particles (concentrations in the 
immobilisation phase were 40 µg/ml in PBS for NoV VLPs and 60 µg/ml in PBS for NoV P-particles), 
the steps after H202-oxidation and the possible challenge step were as follows: 9) Serum sample 
dilutions were applied for 6 minutes. 10) Anti-human IgG labelled with HRP (Vector laboratories 
Inc., USA, dilution 1:800 in buffer) was applied for 6 minutes. 11) Finally, DAB-enhancement phase 
was performed for 6 minutes. DAB was supplied by Thermo (Thermo Scientific, Rockford, IL, USA) 
and used as instructed by the supplier. HRP specifically bound to the sensor surfaces oxidises DAB, 
which subsequently precipitates on the sensor surface, causing an enhanced BLI signal.  
In the case of SA-sensors functionalised with biotin-IDA, a typical run consisted of the following 
steps: 1) Measurement baseline was recorded for 1 minute. 2) 100 nM Biotin-IDA was applied for 
6 min. 3) After each binding phase the sensors were washed with PBS for 5 minutes. 4) His-tagged 
nChiAvd (50 µg/ml in PBS) was immobilised on the sensors for 6 minutes. 5) Sensors were 
challenged with 0.7 M imidazole, or 1 M acetic acid pH 2 for 6 minutes. 7) The binding of the 
second layer protein, biotinylated-BSA (50 μg/ml in PBS) was measured for 6 minutes. 
 
8 
 
2.4. Enzyme-linked immunosorbent assay (ELISA) 
The NoV antibodies from human serum samples were quantified by ELISA assays that were 
performed essentially as described before [24, 29, 38]. Briefly, NoV VLPs (50 ng/well) and Nov P-
particles (50 ng/well) were used as coating antigens in the ELISAs conducted with human sera. All 
reagents and test samples were diluted in 1% skimmed milk in phosphate-buffered saline 
(PBS)/0.05% Tween 20, and the plates were washed with PBS/0.05% Tween 20 between each 
incubation step. 96-well high binding microtitre plates were coated with the NoV particles (Costar, 
Corning, NY) overnight at 4°C and a concentration of 0.5 µg/ml. Two-fold serial dilutions of serum 
samples were carried out to obtain a dilution range of 1:100 – 1:102,400 and were added to plates 
that had been blocked with 5% skimmed milk in PBS for 1 h at 22°C. Antibodies that bound the 
NoV particles were then detected with goat anti-human IgG (H+L)-HRP (1:30,000) (Invitrogen, 
USA) for 1 h at 37°C, followed by 0.4 mg/ml SIGMAFAST™ OPD substrate (Sigma, Germany) for 15 
minutes at 22°C with the final addition of 25 µl of 2 M H2SO4 to stop the reaction. The optical 
density (OD) was measured at 490 nm on a Victor2 1420 Multilabel Counter (Wallac, Perkin Elmer) 
plate reader. Blank wells were incubated with buffer lacking VLPs and the data is expressed as the 
average OD of duplicate wells from a single experiment. 
 
2.5. Synthesis of Biotin-IDA 
2.5.1. Synthesis of Biotin-PEG3-iminodiacetic acid, di-tert-butyl ester 
20 mg biotin-PEG3-amine (48 µmol, purchased from ThermoFisher Scientific), 32.9 mg potassium 
carbonate (238 µmol, 5 equiv.) and 7.9 mg potassium iodide (48 µmol, 1 equiv.) were suspended 
in 219 µl dimethylformamide in an argon atmosphere. 35.1 µl tert-butyl bromoacetate (238 µmol, 
5 equiv.) was then added drop wise to the stirred suspension at room temperature and stirring 
was continued overnight. 1.1 ml ethyl acetate was added to the mixture and the organic solution 
was washed three times with 0.2 ml saturated sodium bicarbonate and three times with 0.2 ml 
brine. The organic phase was separated, dried with anhydrous sodium sulphate and concentrated 
under reduced pressure. Then, the crude product was dissolved in dimethylsulfoxide and 
subsequently the solvent, together with high boiling impurities, was removed at 1-10 Pa to obtain 
22.6 mg biotin-PEG3-iminodiacetic acid, di-tert-butyl ester (34.9 µmol, 73 %). The details of the 
1H-
NMR of the molecule as well as a schematic illustrating the synthesis (Fig. S2) can be found in the 
supplementary information.  
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2.5.2. Synthesis of Biotin-PEG3-iminodiacetic acid 
22.6 mg di-tert-butyl iminodiacetate-PEG3-biotin (35 µmol) was dissolved in 350 µl dry 
dichloromethane and 350 µl trifluoroacetic acid was added. The mixture was stirred for 3 h under 
an argon atmosphere. The product formation was controlled by thin-layer chromatography (Rf = 
0.36; chloroform/methanol/ammonia = 8/2/0.2). After complete conversion of educt into product 
the solution was diluted with 7 ml toluene, the solvents were removed under reduced pressure, 
chloroform was added and then removed at reduced pressure (2x) to obtain 18.5 mg biotin-PEG3-
iminodiacetic acid (28.5 µmol, 82 %). The details of the 1H-NMR of the molecule can be found in 
the supplementary information. 
 
2.6.  Homology modelling 
Structure determined for chimeric avidin [39] was used as a template to build a homology model 
of N-terminally His6-tagged charge-neutralized chimeric avidin mutant [17] using Modeller 9.16 
[40]. The coordinates of NMR structure of chimeric avidin in biotin-bound form were obtained 
from protein data bank (PDB id 2MF6). Structural alignment of the individual subunits generated 
by Modeller were structurally superimposed using Bodil 0.81 [41]. The resulting tetrameric 
structure was then rendered using VMD 1.91 [42]. The coordinates of the bound biotins missing in 
the chimeric avidin structure (PDB id 2MF6) were obtained by superimposing the nChiAvd model 
with chicken avidin biotin complex X-ray structure (PDB id 2AVI; [43]). Adobe Photoshop CS6 was 
used to finalize the figure. 
 
3. Results and discussion 
3.1. Effect of the sensor chemistry on ligand binding and analyte binding 
In order to achieve efficient cobalt-mediated immobilization of His-tagged proteins, we first 
optimized the immobilization chemistry and conditions. NTA and IDA are both widely used as 
carriers for metal immobilization. In a previous study, IDA-captured cobalt was used for antibody 
immobilization for preparation of affinity capture chromatography resin [4]. We therefore 
synthesized IDA-biotin and compared the performance of streptavidin sensors functionalized with 
IDA-biotin to commercially available NTA-functionalized sensors. These experiments were 
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performed by using ambient conditions. Fig. 2A indicates the differences in the amount of protein 
bound to different BLI sensor surfaces: the Co-NTA surfaces bound the highest amount of protein 
leading to a total response of ~12 nm, while Ni-NTA surfaces resulted in an ~8 nm response. 
Streptavidin sensors functionalized with Co-IDA resulted in only an ~2 nm binding response. These 
results may be explained by the fact that NTA-sensors utilize tris-NTA [33] chemistry, and thus 
potentially offer higher numbers of binding sites for His-tagged proteins per sensor surface area 
when compared to IDA-functionalized streptavidin sensors. The thickness of the immobilized layer 
is above the diameter of avidin protein (~5 nm), suggesting arrangement where more than one 
layer of proteins becomes bound to Co-NTA and Ni-NTA sensors. This may result from sensor 
surface having certain amount of roughness and thus multilayer protein arrangement. 
Unfortunately, the details of the biosensor surface architecture are not available. 
 
[Figure 2 here] 
 
 Fig. 2. Optimization of the sensor functionalization. (A) The amount of the ligand, His-tagged 
avidin protein, bound to the Co-IDA, Ni-NTA or Co-NTA BLI sensor surfaces. (B) The amount of the 
second layer protein, biotinylated-BSA, bound to the BLI-sensors, comparing the sensor chemistry 
and whether or not the surfaces were imidazole challenged prior to the second layer protein 
binding. The results are an average of 3 individual sensors ± SD. 
 
Fig. 2B shows the amount of the second layer protein (biotinylated-BSA) bound to the sensors 
after challenging the surface with 0.7 M imidazole. This condition is known to severely disturb 
weak metal-histidine interactions and is typically used, for example, in detaching proteins from Ni-
NTA columns when performing protein purification. We observed that oxidized Co-NTA and Co-
IDA sensors are capable of binding the same amounts of 2nd layer protein regardless of whether 
either imidazole challenged or non-challenged surfaces were used.  In contrast, imidazole-treated 
Ni-NTA sensors caused the detachment of the majority of the ligands (~80%) from the surface, 
resulting in lower amounts of 2nd layer protein binding. 
3.2. Consequence of the oxidation time and H202 concentration on sensor stability 
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One of the benefits of the use of biosensors is that they enable quicker assays as compared to 
methods such as ELISA. Therefore, we were interested to optimize the length of oxidation time 
needed for efficient immobilization of the His-tagged ligand. We thus studied the effect of 
oxidation time (5-60 min) and the H202 concentration (0.03%; 0.06%; 0.3%) on sensor stability. 
Figure 3 indicates that sensors challenged with imidazole (0.7 M) released over 70% of ligands 
from cobalt-functionalized sensors. In contrast, the oxidized cobalt sensors released only 30-40% 
of the ligands after such treatment. With the nickel sensors, more than 90% of the ligands 
detached. Low pH (1 M acetic acid pH 2) was also tested in the challenge of the surfaces, and 
similar values were obtained. It was observed that with cobalt-sensors the longer oxidation times 
and higher H202 concentrations resulted in lower protein detachment after challenge.  
We observed correlation between the amount of detached protein and the time period of 
oxidation; the longer the oxidation, the less ligand was detached (Fig. 3B). However, the 
differences between longer oxidation times were fairly small and consequently, an oxidation time 
of 10-15 minutes, combined with 0.3% H202 was used in the following experiments. 
[Figure 3 here] 
 
 Fig. 3. Stability of the immobilized layer. (A) The amount of the ligand (His-tagged avidin) 
detached from the sensor surfaces when challenged with imidazole, depended on the hydrogen 
peroxide concentration induced sensor oxidation. Oxidation was performed for 10 and 30 minutes. 
(B) The amount of the ligand detached in imidazole challenge, depended on the sensor hydrogen 
peroxidase oxidation time (0.3% H202). Control samples were treated for 10 minutes with PBS 
instead of oxidation with hydrogen peroxide. The results are an average of 3 individual sensors ± 
SD. 
 
3.3  Spontaneous oxidation and influence of reduction on sensors  
The use of oxidizing agent may not be suitable for all the proteins because it potentially causes 
damage to protein structure. We noticed that the differences between the cobalt-functionalized 
sensors oxidized with H202 or washed simply “in buffer” were smaller than expected when 
compared to nickel-functionalized sensors challenged with imidazole (Fig. 3). In other words, we 
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assumed that in a similar manner to the nickel sensors, almost all of the ligands should have 
detached from the cobalt-NTA sensors during the challenge. We thus hypothesized that cobalt-
functionalized sensors may become partially oxidized due to ambient conditions. In the following 
experiment, we tested this hypothesis through the inclusion of the reducing agent (β-
mercaptoethanol) in all solvents used in the experiment. We observed the following outcomes: 1) 
the amount of immobilized His-tagged protein was significantly lower in the presence of reducing 
agent when compared to conditions without reducing agent (Fig. 4). This may indicate that 
spontaneous oxidation of the cobalt takes place during the immobilization phase, thus increasing 
the amount of immobilized ligand due to irreversible binding to sensor. In the presence of 
reducing agent, the amount of immobilized His-tagged avidin is comparable to that observed for 
the Ni-NTA sensor (Fig. 2). 2) Another principal finding was that the sensor treated in the presence 
of reducing agent released, when challenged, clearly higher proportions of the immobilized ligand 
when compared to the sensor prepared in the buffers free of reducing agent (Fig. 3A). We assume 
that these observations are due to spontaneous oxidation taking place as a result of the presence 
of dissolved oxygen in the buffers. Spontaneous oxidation may be a preferred method for tight 
immobilization of delicate proteins, which might not withstand the harsher H202-treament. 
[Figure 4 here] 
 
Fig. 4. Effect of the oxidation treatment for the stability of the immobilized ligand layer. 
(A) Sensorgrams of H202-oxidized, spontaneously oxidized and β-mercaptoethanol reduced cobalt-
NTA sensors. The corresponding amounts of (B) bound or detached proteins or (C) the second 
protein layer (biotinylated-BSA) binding depending on the sensor chemistry. The results in panel B 
and C are an average of 2 individual sensors ± SD. 
 
The amounts of the avidin-ligand bound or detached in challenge and the amount of the 2nd layer 
protein bound were compared in relation to oxidation or reduction as shown in Figs. 4B and 4C. 
2nd layer protein binding depended on the sensor chemistry and were 0.3 nm for β-
mercaptoethanol-reduced, 1.2 nm for H202-oxidized or 1 nm for spontaneously oxidized sensors 
respectively. Overall, the oxidized cobalt sensor was the most resistant surface to 0.7 M imidazole 
treatment (Fig. 4B). This resistance to imidazole treatment also correlated with the highest 
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amount of bound biotinylated-BSA in the following phase (Fig. 4C). As expected, the reduced 
sample containing the β-mercaptoethanol also bound the lowest amount of biotinylated-BSA (Fig. 
4C).  
With this in mind, we hypothesize that cobalt, when used for affinity chromatography, may also 
oxidize spontaneously and thus cause tight immobilization of the His-tagged protein to the 
column. Therefore, if the desire is to maximise the yield in chromatographic purification whilst 
utilising cobalt, it may be advisable to include small amounts of reducing agent in order to avoid 
irreversible binding of the target protein into the chromatographic column. 
 
3.4  Does the oxidation damage the immobilized proteins? 
The experiments described above suggest that cobalt is suitable for tight immobilization of His-
tagged proteins. However, it is also important to ensure that this methodology is suitable for 
applications where relevant ligands are immobilized for use in investigations with patient samples. 
In order to evaluate the effects of oxidation step for the immobilized protein layer, we conducted 
an experiment with two different norovirus-related proteins. P-particles are artificial assemblies of 
norovirus capsid proteins, while nVLPs represent the natural virus in terms of the morphology. 
Therefore, these particles are good examples of biological materials used in the biosensor 
analyses.  
These antigens were immobilized to Co-NTA or Ni-NTA sensors. Selected Co-NTA sensors were 
then oxidized after the immobilization of the ligand using the protocol described above while 
reference sensors were soaked in PBS. Then, by using serum from patient with strong response to 
norovirus proteins [24, 29], the state of the immobilized antigen after oxidation was determined. 
The measured response after DAB enhancement is shown in Fig. 5. We found oxidation of the 
cobalt-immobilized sensor to show 3% (P-particle) or 13% (nVLP) higher response as compared to 
cobalt sensor treated in ambient conditions.  
Importantly, the response measured with Co-NTA sensors were higher regardless of the oxidizing 
treatment as compared to Ni-NTA sensors: the measured increase in the binding response was 
smallest in the case of non-oxidized cobalt as compared to nickel for P-particle (1%), while highest 
increase was observed for oxidized cobalt functionalized nVLP sensor, where more than 100% 
enhancement was seen as compared to nickel-functionalized reference. Therefore, based on this 
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data, the oxidation does not cause severe damage to immobilized proteins, and is suitable for 
biologically relevant norovirus antigens. 
[Figure 5 here] 
Fig. 5. Comparison of pHis or nVLP functionalized sensor responses with norovirus positive serum 
samples depending on the sensor chemistry: non-oxidized nickel, non-oxidized cobalt or oxidized 
cobalt. Results are an average of 2 independent sensors ± SD. 
 
3.5.  Feasibility of cobalt sensor use for the analysis of human serum samples 
One of the main problems encountered in our previous study [29] was the detachment of the 
ligands from the BLI-sensors due to the presence of interfering agents (such as EDTA) in some of 
the solutions used. Therefore, in the previous study, the His-tagged ligands were further 
immobilized via NHS-EDC to BLI Ni-NTA sensors in order to prevent their leakage during the 
analysis. 
In order to evaluate the stability of the biofunctionalization layer, the sensors coated with 
norovirus P-particles were subjected to imidazole challenge prior to the introduction of the serum 
samples. Figure 6 shows that Ni-sensors (oxidized with 0.3% H202, as the Co-sensors), deliver no 
detectable signals for NoV antibody binding after imidazole treament. In comparison, robust 
signals were obtained with the oxidized cobalt-sensors.  
Detachment of NoV P-particle ligands from the sensors was quite drastic, especially with the nickel 
sensors: over 95% of the ligands were detached with 0.7 M imidazole, whilst there was 65% ligand 
detachment with the oxidized cobalt sensors (Fig. 6A, phase 4). In comparison, the avidin ligands 
showed less efficient detachment (over 70% with non-treated cobalt sensor and about 35% with 
oxidized cobalt; Fig. 3A). This may be a reflection of differences in the ligand-protein 
characteristics: avidin is a tetrameric protein with an extremely stable tetramer assembly. In 
contrast, the norovirus P-particle is a loose assembly of 24 subunits, which may partially dissociate 
when treated with 0.7 M imidazole. However, importantly, the cobalt-based NoV-particle-
functionalized surface is capable of recognizing antibodies in human serum, while the nickel-
functionalized sensors completely lost their antibody-binding capacity in the imidazole treatment 
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(Fig. 6B). A schematic illustration of NoV particle on BLI-sensor surface and the following BLI assay 
steps utilized in this study can be found from the supplementary information (Fig S3A.). 
 
 
[Figure 6 here] 
 
Fig. 6. Use of cobalt-functionalized sensors for quantification of serum antibodies. (A) BLI-
sensorgrams for NoV P-particle immobilization on cobalt- (blue) or nickel-functionalized (red) 
sensors. These sensors were used to detect antibodies from norovirus positive serum samples 
diluted 1:100 (phase 5). Phases 6 and 7 show HRP-labelled anti-human IgG binding and DAB 
enhancement, respectively. (B) Comparison of the BLI assay and ELISA for detection of NoV 
antibodies from human serum samples using NoV P-particle as an antigen. Grey lines represent the 
ELISA results, red lines the BLI results gained with oxidized cobalt sensors, and blue lines oxidized 
nickel sensors, both challenged with 0.7 M imidazole prior to serum samples. Representative 
results based on 8 independent sensors are shown, the assay was repeated with similar results. 
 
As noted in the previous study [29], serum alone induces a signal with BLI, but there are no 
differences between the response obtained from norovirus-positive donor serum and negative 
control serum samples prior to the DAB enhancement –phase. This suggests that the serum 
proteins do bind in an unspecific manner to the sensors, and therefore, the use of a secondary 
antibody against primary serum antibodies is needed to determine the amount of specifically 
bound primary antibodies. 
Histidine tags can be straightforwardly added to the N- or C- terminus of proteins (or positioned in 
flexible regions within the protein) and have thus been widely employed for protein purification 
purposes. In this regard, the reversibility of the binding between the histidine-tag and nickel-NTA 
has been a positive trait, enabling the efficient release of bound proteins. However, biosensing 
applications and other protein immobilization protocols may require tighter conjugation methods. 
In addition, the presence of additives like EDTA and imidazole in protein solutions can also disturb 
histidine-nickel bonding. 
16 
 
Fluidics-free BLI is a method that is very well suited for the screening of difficult and even “dirty“ 
samples, such as serum, urine or stools or it can be used, for example, for different kinds of 
industrial process samples. For these types of sample, the immobilized ligands must also be 
robust; the ligand must remain immobilized throughout the whole analysis cycle. Previously, Hale 
[4] and Wegner et al. [5-6] also studied Co-NTA immobilization of His-tagged proteins. Their main 
findings were that there is tighter affinity in cobalt-bonding compared to nickel-bonding, and that 
oxidized Co-NTA is tolerant to EDTA and other reducing agents including cysteamine, DTT, TCEP 
and ascorbate. However, this is, to our knowledge, the first study where the high performance of a 
Co-NTA immobilization strategy combined with oxidation is demonstrated using serum samples 
and through the use of BLI sensor technology. The methodology presented is well suited for fast 
screening of samples. Ligand immobilization can be done in advance, and if, for example, only 
diagnostic samples are used, the last phases presented in this article could be run and results 
gained within 5-15 minutes. There is a clear need for these types of fast, yet very robust analytics 
where results are measurable straight from difficult sample matrices. 
 
4.  Conclusions 
Oxidized cobalt sensors performed well in biosensor functionalization. 1) The amount of 
immobilised ligand is clearly higher when compared to Ni-NTA sensors. 2) The amount of ligand 
retained on the sensor after challenge is high (70-95%). 3) The amount of the second layer protein 
bound remains reasonable. 4) We did not observe decrease in antigen-antibody binding due to 
oxidation. Spontaneous oxidation occurring due to the presence of dissolved oxygen may enable 
the utilization of this method for oxidation labile proteins. This means in practise, that this method 
is potentially exploitable without any special oxidation steps, unless, of course, the use of 
oxidation is desired for a faster process. This assay design is well suited for fast analysis of, for 
example, clinical samples, as demonstrated here. The different BLI assay phases can easily be 
quickened and/or shortened in order to reduce the current run time to 10-20 minutes, or even 
less, if ligand immobilization is performed beforehand. 
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